Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Recombination of human soluble TRAIL protein, the preparing method and the application in preparing antineoplastic medicine

A soluble protein technology, applied in the direction of recombinant DNA technology, botany equipment and methods, biochemical equipment and methods, etc., can solve the problem of normal cell killing

Inactive Publication Date: 2004-06-02
李宏
View PDF2 Cites 20 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among them, surgical resection has its limitations, while radiotherapy and chemotherapy have the following disadvantages: 1. It has obvious killing effect on normal cells; 2. Many tumor cells are resistant to treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombination of human soluble TRAIL protein, the preparing method and the application in preparing antineoplastic medicine
  • Recombination of human soluble TRAIL protein, the preparing method and the application in preparing antineoplastic medicine
  • Recombination of human soluble TRAIL protein, the preparing method and the application in preparing antineoplastic medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0066] The present invention will be described in detail below in conjunction with the accompanying drawings and specific embodiments, and the described embodiments are used to describe the present invention rather than limit the present invention.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses recombinant soluble human tumore necrosis factor related death inducing ligand and its preparation process and application in preparing antitumor medicine. The present invention adopts human tonsil tissue mRNA as template to amplify TRAIL coding sequence, constitute engineering colibacillus for expressing rhsTRAIL and engineering saccharomycete, establish the rhsTRAIL engineering colibacillus fermentation, occlusion body washing and destination protein purification process and the engineering saccharomycete and destination protein purification process separately, and obtain pure rhsTRAIL product, which has molecular weight of 19.6-24 KD and exists in both monomer and dimmer. The rhsTRAIL can induce death of several kinds of cancer cells outside body, inhibit amplification of liver cancer cell in tumor loading mouse obviously and kill tumor cell selectively, so that it may be used in preparing effective antitumor medicine.

Description

field of invention [0001] The present invention relates to recombinant human soluble TRAIL protein, its preparation method and its application in the preparation of anti-tumor drugs, specifically, the present invention relates to tumor necrosis factor-related apoptosis ligand (hereinafter referred to as TRAIL protein) gene cloning, The preparation method and its application in the preparation of anti-tumor drugs, the TRAIL protein has the effect of inducing tumor cell apoptosis in vitro and anti-tumor in vivo, can be used for the treatment of various tumors, and has potential application value in the treatment of clinical tumors . Background technique [0002] At present, the morbidity and mortality of malignant tumors are still increasing year by year, becoming the first or second fatal disease. The treatment of tumor mainly depends on the three major therapies of radiotherapy, chemotherapy and surgical resection. Among them, surgical resection has its limitations, while ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/17A61P35/00C07K14/435C07K14/47C12N15/12C12N15/63C12P21/02
Inventor 李宏
Owner 李宏
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com